Shun-Ichi Kurata
Overview
Explore the profile of Shun-Ichi Kurata including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
14
Citations
206
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Katoh I, Tsukinoki K, Hata R, Kurata S
Neoplasia
. 2023 Oct;
45:100938.
PMID: 37778252
TP63 (p63) is strongly expressed in lower-grade carcinomas of the head and neck, skin, breast, and urothelium to maintain a well-differentiated phenotype. TP63 has two transcription start sites at exons...
2.
Yang X, Ozawa S, Kato Y, Maehata Y, Izukuri K, Ikoma T, et al.
Int J Mol Sci
. 2019 Apr;
20(8).
PMID: 31014014
Cancer is a leading cause of death and disease worldwide, with a tremendous financial impact. Thus, the development of cost-effective novel approaches for suppressing tumor growth and progression is essential....
3.
Katoh I, Maehata Y, Moriishi K, Hata R, Kurata S
Neoplasia
. 2019 Apr;
21(5):494-503.
PMID: 30986748
TP63 (p63), a member of the tumor suppressor TP53 (p53) gene family, is essential for ectodermal tissue development and suppresses malignant progression of carcinomas. The most abundant isoform, ΔNp63α (referred...
4.
Katoh I, Fukunishi N, Fujimuro M, Kasai H, Moriishi K, Hata R, et al.
Cell Cycle
. 2016 Feb;
15(5):699-710.
PMID: 26890356
Submitted: TP63 (p63), a member of the tumor suppressor TP53 (p53) gene family, is expressed in keratinocyte stem cells and well-differentiated squamous cell carcinomas to maintain cellular potential for growth...
5.
Katoh I, Kurata S
Front Oncol
. 2013 Sep;
3:234.
PMID: 24062987
Since the human genome sequences became available in 2001, our knowledge about the human transposable elements which comprise ∼40% of the total nucleotides has been expanding. Non-long terminal repeat (non-LTR)...
6.
Katoh I, Mirova A, Kurata S, Murakami Y, Horikawa K, Nakakuki N, et al.
Neoplasia
. 2011 Dec;
13(11):1081-92.
PMID: 22131883
The human and Old World primate genomes possess conserved endogenous retrovirus sequences that have been implicated in evolution, reproduction, and carcinogenesis. Human endogenous retrovirus (HERV)-K with 5'LTR-gag-pro-pol-env-rec/np9-3'LTR sequences represents the...
7.
Fukunishi N, Katoh I, Tomimori Y, Tsukinoki K, Hata R, Nakao A, et al.
Neoplasia
. 2010 Dec;
12(12):969-79.
PMID: 21170261
The expression of p63 (TP63/p51) occurs in the basal cells of stratified epithelia and is strongly enhanced at the early stages of squamous cell carcinomas (SCCs) of the head and...
8.
Katoh I, Sato S, Fukunishi N, Yoshida H, Imai T, Kurata S
Cell Res
. 2008 Jul;
18(12):1210-9.
PMID: 18663378
To explore how the intrinsic apoptosis pathway is controlled in the spontaneous fog (forebrain overgrowth) mutant mice with an Apaf1 splicing deficiency, we examined spleen and bone marrow cells from...
9.
Watanabe T, Totsuka R, Miyatani S, Kurata S, Sato S, Katoh I, et al.
Cell Tissue Res
. 2005 Jun;
321(2):185-93.
PMID: 15951990
Mouse milk fat globule-EGF factor 8, MFG-E8, is the ortholog to the human mammary tumor marker, lactadherin, and comprises two spliced variants, the L and S forms. Recent studies have...
10.
Kurata S, Okuyama T, Osada M, Watanabe T, Tomimori Y, Sato S, et al.
J Biol Chem
. 2004 Sep;
279(48):50069-77.
PMID: 15361520
p51/p63, a member of the tumor suppressor p53 gene family, is crucial for skin development. We describe here identification of ITGA3 encoding integrin alpha(3) as a target of its trans-activating...